Format

Send to

Choose Destination
Expert Rev Clin Pharmacol. 2014 Jul;7(4):457-68. doi: 10.1586/17512433.2014.922864.

The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond.

Author information

1
Department of Primary Care and Population Health, University College London, London, UK.

Abstract

There is general agreement that the growth of the numbers of older people throughout the world has significant implications for both health and social care and for the prevention and treatment of disease and disability. The optimum use of pharmaceuticals and possibly nutraceuticals is, and will to a greater extent, therefore be of crucial importance. A snapshot of the current status of older people in relation to the issues discussed in this review is provided in an informative report published by Age UK.

KEYWORDS:

cardiovascular disease; clinical trial; drug treatment; older people; patients view

PMID:
24939469
DOI:
10.1586/17512433.2014.922864
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center